✦ LIBER ✦

Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents

✍ Scribed by Rustomjee, R.; McClain, B.; Brennan, M.J.; Mcleod, R.; Chetty-Makkan, C.M.; McShane, H.; Hanekom, W.; Steel, G.; Mahomed, H.; Ginsberg, A.M.; Shea, J.; Lockhart, S.; Self, S.; Churchyard, G.J.

Book ID: 121682862
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 344 KB
Volume: 93
Category: Article
ISSN: 1472-9792
DOI: 10.1016/j.tube.2012.11.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label, single arm, phase III cli

An open-label, single arm, phase III clinical study to evaluate the efficacy and safety of CJ smallpox vaccine in previously vaccinated healthy adults

✍ Kim, Nak-Hyun; Kang, Yu Min; Kim, Gayeon; Choe, Pyoeng Gyun; Song, Jin Su; Lee, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 499 KB

Efficacy and safety profiles of a new S(

Efficacy and safety profiles of a new S(—)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: An 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial

✍ Sung Ai Kim; Sungha Park; Namsik Chung; Do-Sun Lim; Joo-Young Yang; Byung-Hee Oh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 203 KB